Enrollment for the RESOLVE-AF trial in the Czech Republic is off to a great start! Principal Investigator Prof. Petr Neuzil and Sub-Investigator Dr. Jan Petru and their team completed their first 6 cases at Homolce Hospital this week. Visit CortexEp.com to learn more

1st cases in Czech Republic! Congrats to Dr. Martin Fiala and his colleagues at Neuron Medical in Brno for completing their 1st procedures using the OptiMap™ System today! This initiates the 1st Czech site in the RESOLVE-AF clinical trial. CortexEP.com #EPeeps #EP #AF

Congrats to @tomdepotter & the #EPeeps at @OLVZaalst for completing their first 2 procedures using the OptiMap™ System today! This initiates the second site in Belgium in the RESOLVE-AF clinical trial. We're delighted to have Dr. de Potter & @OLVZaalst in this study!

First in Belgium! Congrats to Dr. Michael Wolf and the #EPeeps at ZNA - Ziekenhuis Netwerk Antwerpen for performing Belgium's first procedure using the OptiMap™ System, as part of the RESOLVE-AF clinical trial.

The conversations we had with the hundreds of physicians and industry professionals who came by our booth at #HRS2024 confirms our belief that the OptiMap™ System will fill a vital unmet need for understanding the underlying pathophysiology of AF, esp. in complex redo cases.

TODAY at #HRS2024 Rhythm Theater 1, 9:15-10:00am See What Matters with EGF™ @atulverma_md, @Kent_Nilsson_EP, Dr. Ilana Kutinsky & @su_Wilber Learn more about the OptiMap™ System in presentations by: Dr. Mangrum – 10:30am–12:30pm Dr. Reddy – 1:30–3:30pm buff.ly/3UZEmPh

Join us TOMORROW at #HRS2024 for a Rhythm Theater presentation. Hear from @atulverma_md, @Kent_Nilsson_EP, Dr. Ilana Kutinsk, & @su_wilber how Electrographic Flow™ mapping with the OptiMap™ System is being used by physicians in complex AF cases. #Epeeps #EP

TODAY at #HRS2024 Learn how the OptiMap™ System helps physicians See What Matters in presentations by Dr. Kutinsky (Poster Session I) & @Kent_Nilsson_EP & Dr. Szili-Torok (both, Poster Session III) buff.ly/3UZEmPh #EPeeps #EP #AF

At #HRS2024, meet the 510k cleared OptiMap™ System, an Electrographic Flow™ (EGF) mapping solution designed with AI, enabling physicians to See What Matters. -Rhythm Theater 9:15am 5/18 -Booth 869 -5 Presentations Details here: cortexep.com/hrs-2024 #EPeeps #EP

Join us at #HRS2024 for a Rhythm Theater presentation. Hear from @atulverma_md, @Kent_Nilsson_EP, Dr. Ilana Kutinsky & @su_Wilber how Electrographic Flow™ mapping with the OptiMap™ System is being used by physicians in complex AF cases. #Epeeps #EP

At #HRS2024, meet the 510k cleared OptiMap™ System, an electrographic flow (EGF) mapping solution designed with AI, enabling physicians to See What Matters. -Rhythm Theater 1 | 9:15-10am Sat, 5/18 -Booth 869 -5 Presentations cortexep.com/hrs-2024 #Epeeps #EP #Afib #AF

We look forward to seeing you in Boston at #HRS2024! Visit our booth to learn about the 510(k) cleared OptiMap™ System, an Electrographic Flow™ (EGF) mapping solution designed with AI that enables physicians to See What Matters. See all of our events: cortexep.com/hrs-2024

The international RESOLVE-AF trial enrolled its first EU patient today as Dr. Max Liebregts completed the first case. @boersma_lucas, the EU PI, said, “I’m excited to participate in this study to evaluate Cortex’s EGF mapping as promising approach to identify extra-PV sources.”

Our CTO, Philip Häusser, recently had a conversation with Germany's Federal Health Minister, Karl Lauterbach, at the Digital health summit #DMEA24.

To hear more about our new RESOLVE-AF trial, listen to this recent episode of the MassDevice Fast Five podcast. The segment on the trial begins at 3:29.

Excited to announce the initiation of our RESOLVE-AF trial. This trial aims to demonstrate that EGF mapping can be used to identify EGF sources outside the pulmonary veins in all types of patients, aiding physicians in their treatment strategy. prnewswire.com/news-releases…

Thanks to @MichelleF_Davis @Bloomberg for breaking the story on the formation of Cortex to pursue a fully integrated solution suite designed to enable more precise therapy planning and delivery and optimize clinical outcomes and safety for AFib patients. bloomberg.com/news/articles/…

Announcing the formation of Cortex, a new comprehensive AFib ablation technology company, with $90M investment led by KKR & H&F. Our integrated solution will include diagnostic and therapeutic PFA catheters supported by innovative mapping technology. prn.to/3Gw2yk6